Navigation Links
New Anti-Clotting Drug Shows Promise in Heart Patients
Date:11/4/2007

ing percutaneous coronary intervention [PCI, also known as angioplasty]," said study senior author Dr. Elliott M. Antman, a professor of medicine at Harvard Medical School and director of the Samuel A. Levine Cardiac Unit at Brigham and Women's Hospital in Boston.

Only 9.9 percent of participants taking prasugrel died from cardiovascular causes, compared with 12.1 percent of patients taking Plavix, a 19 percent reduction. Prasugrel was also associated with a lower incidence of stent thrombosis, revascularization and heart attack.

On the other hand, the incidence of major bleeding was significantly higher with prasugrel -- 2.4 percent vs. 1.8 percent of patients on Plavix.

Still, Antman pointed out, prasugrel came out ahead.

"There were 24 fewer cardiovascular deaths with prasugrel and 16 more bleeding-related deaths so the net tally was nine fewer total deaths, which is not statistically significant," Antman said. "[But] what's important here is we believe we know where the majority of excess bleeding and most of the fatal bleeding occur -- those with prior stroke or TIA [transient ischemic attack] probably shouldn't get prasugrel, the elderly and those with a low body weight would probably benefit from a reduced maintenance dose."

A second study presented at the press conference found that a nuclear imaging technique that measures blood flow in the heart can identify which patients will benefit more from undergoing percutaneous coronary intervention than receiving medical therapy alone for blocked coronary arteries. The trial was supported by Bristol Myers-Squibb Medical Imaging and Astellas Healthcare.

Another trial found that Integrilin (eptifibatide) was as effective as ReoPro (abciximab) in restoring blood flow to the heart in patients undergoing PCI.

"Preliminary clinical events did not show any differences, therefore eptifibatide seems a valid alternative to abciximab in patients with pri
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. FDA Approves New Anti-Clotting Drug
2. Aspirin surpasses Modern Anti-clotting Drugs
3. Enduring anti-clotting treatment avails heart patients
4. New Anti-Clotting Drug Less Risky For Heart Attack Patients
5. Bivalirudin, a new anti-clotting drug may be a safer option for treatment of acute coronary conditions
6. Warfarin’s Anti-clotting Property May Cause Hemorrhagic Stroke
7. Experimental treatment for Ebola Virus Shows promising results in mice
8. Gene Therapy shows promise in treating Hemophilia
9. New Prostate Cancer Vaccine Shows Promise
10. Leukemia pill shows promise against stomach cancer
11. Stent shows promise in keeping arteries open
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Anti-Clotting Drug Shows Promise in Heart Patients
(Date:8/27/2015)... ... 2015 , ... According to an article published August 13 by ... many conversations between hernia experts surrounding the search for the ideal hernia mesh. With ... experts have different ideas about which is the best mesh for their patients. What ...
(Date:8/27/2015)... ... 27, 2015 , ... In an article published July 30th by ... of New Orleans, highlighting a security firm that is tasked with providing supplemental protection. ... entrepreneur who worked with the city to provide private security when it is needed ...
(Date:8/27/2015)... PA (PRWEB) , ... August 27, 2015 , ... ... Health Network , is one of just 20 adult-only medical centers in the ... for people with failing hearts and lungs. The Extracorporeal Life Support Organization ...
(Date:8/27/2015)... ... August 27, 2015 , ... On May 30th, 2015, at the Adams County ... of the “Music With A Mission” benefit concert. For the past two years, “Music ... the underfunded school districts of Mendon and neighboring town, Quincy, IL. Organized in part ...
(Date:8/27/2015)... PLAINSBORO, N.J. and WILMINGTON, Del. (PRWEB) , ... August 27, 2015 ... ... at Texas Children’s Hospital, will be the guest speaker at CURE® magazine’s 3rd ... meeting of hematologists. , Dr. Arnold will be among hundreds of attendees honoring eight ...
Breaking Medicine News(10 mins):Health News:Recent Article on Hernia Mesh Developments Highlights Viable Options, But Shows a Need for Further Research, notes Dr. Shirin Towfigh 2Health News:Article on New Orleans Security Force Highlights the Abilities and Flexibility of Private Security, says Spear Security Inc. 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 4Health News:Best Drug Rehabilitation Interviews Madd Hoss Jackson at the 2015 "Music With A Mission" Benefit Concert 2Health News:Dr. Jennifer Arnold of ‘The Little Couple’ to Keynote 3rd Annual MPN Heroes™ Recognition Event in Orlando 2Health News:Dr. Jennifer Arnold of ‘The Little Couple’ to Keynote 3rd Annual MPN Heroes™ Recognition Event in Orlando 3Health News:Dr. Jennifer Arnold of ‘The Little Couple’ to Keynote 3rd Annual MPN Heroes™ Recognition Event in Orlando 4
... offers tips on digestive disorders , , SATURDAY, March 28 (HealthDay ... a one-time bellyache, but it also could be a sign ... Boland, chief of gastroenterology at Baylor University Medical Center in ... digestive disorders: , Symptoms : Alert your ...
... safe and superior to bare metal stents in preventing ... in a nationwide registry of cardiovascular disease, according to ... findings were presented today at the i2Summit at the ... also appear online in the Journal of the ...
... more than $19 billion dollars of funding provided for ... stimulus package offers a unique opportunity to deliver on ... Children,s Hospital Boston in a Perspective article published in ... Journal of Medicine (NEJM). The co-authors argue that ...
... DRx Corporation (Nasdaq: VETS ) a provider of ... announced that the Company will release its financial results for ... to the opening of the market on Wednesday, April 1, ... call on Thursday, April 2, beginning at 2:00 p.m. Eastern ...
... to pay restitution of $2.3 billion and forfeit $1.7 ... Enterprises (NCFE) executives were sentenced today for their roles ... health of NCFE, Acting Assistant Attorney General Rita M. ... Southern District of Ohio announced. NCFE, formerly based in ...
... flu shot, will have Tamiflu available for purchase as well. , ... Van Nuys, CA ... influenza virus that is easily caught upon contact with the virus. The flu ... fatal. The best prevention of the flu is to get the annual ...
Cached Medicine News:Health News:What You Need to Know When Your Stomach Aches 2Health News:Drug-eluting stents found safe, superior to bare metal stents 2Health News:Billions spent on health IT stimulus could lead to major boom... or bust 2Health News:Pet DRx to Hold Its Fourth Quarter and Year-End 2008 Financial Results Conference Call 2Health News:Former National Century Financial Enterprises CEO Sentenced to 30 Years in Prison, Co-owner Sentenced to 25 Years in Prison for Conspiracy, Fraud and Money Laundering 2Health News:Former National Century Financial Enterprises CEO Sentenced to 30 Years in Prison, Co-owner Sentenced to 25 Years in Prison for Conspiracy, Fraud and Money Laundering 3Health News:Former National Century Financial Enterprises CEO Sentenced to 30 Years in Prison, Co-owner Sentenced to 25 Years in Prison for Conspiracy, Fraud and Money Laundering 4Health News:Nationwide Medical/Surgical Announces Availability of Tamiflu for the 2009-2010 Influenza Season 2
(Date:8/27/2015)... and TORONTO , Aug. ... (OTCQB: GNBT) today announced the issuance of a white ... proprietary buccal insulin spray product.  The white paper was ... the Company,s stockholders by Dr. James H. Anderson, ... white paper may be viewed online on the Generex ...
(Date:8/27/2015)... Pa. , Aug. 27, 2015  PinnacleHealth CardioVascular Institute ... and second in the United States ... new type of stent for blockages in the main artery ... within the artery and potentially less risk for stent fracture ... is a prospective, single-arm, multicenter clinical trial of the BioMimics ...
(Date:8/27/2015)... , August 27, 2015 ... Persistence Market Research titled "Global Market Study on ... Growth by 2021", the urinary catheters market is expected to ... of 2015. It is anticipated to expand at ... reach US$1,755.0 Mn by 2021. View ...
Breaking Medicine Technology:Generex Announces Issuance of Buccal Insulin White Paper 2Generex Announces Issuance of Buccal Insulin White Paper 3Generex Announces Issuance of Buccal Insulin White Paper 4First Pennsylvania Patient Treated in Landmark Vascular Study 2Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 2Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 3Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 4
... MILFORD, Mass., Nov. 14, 2011 PLC Systems Inc. ... technologies, today reported financial results for the three and ... only include the company,s RenalGuard® operations, since PLC completed ... Novadaq Corp. during the first quarter of 2011. Results ...
... (Nasdaq CM: INSM), a biopharmaceutical company, announced today that Timothy ... corporate overview at the Lazard Capital Markets 8th Annual Healthcare ... in New York. A live audio webcast ... webcast will also be archived for 90 days. ...
Cached Medicine Technology:PLC Systems Reports Third Quarter 2011 Results 2PLC Systems Reports Third Quarter 2011 Results 3PLC Systems Reports Third Quarter 2011 Results 4PLC Systems Reports Third Quarter 2011 Results 5PLC Systems Reports Third Quarter 2011 Results 6Insmed to Present at Lazard Capital Markets 8th Annual Healthcare Conference 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: